(Q37859000)

24 August 2017

1 reference

title

Are all statins the same? Focus on the efficacy and tolerability of pitavastatin (English)

1 reference

24 August 2017

author name string

Pedro Marques da Silva

series ordinal

1

1 reference

24 August 2017

publication date

1 January 2011

1 reference

American journal of cardiovascular drugs

24 August 2017

published in

1 reference

24 August 2017

volume

11

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

93-107

1 reference

Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Inhibitory effect of pitavastatin (NK-104) on the C-reactive-protein-induced interleukin-8 production in human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Global analysis of RNA expression profile in human vascular cells treated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Plaque-Stabilizing Effect of Pitavastatin in Watanabe Heritable Hyperlipidemic(WHHL) Rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Enhanced oxidative stress in neutrophils from hyperlipidemic guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Pitavastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, blocks vascular smooth muscle cell populated-collagen lattice contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Biphasic effect of HMG-CoA reductase inhibitor, pitavastatin, on vascular endothelial cells and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Anti-adipogenic action of pitavastatin occurs through the coordinate regulation of PPARgamma and Pref-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Uptake mechanism of pitavastatin, a new inhibitor of HMG-CoA reductase, in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

OATP1B1 388A>G polymorphism and pharmacokinetics of pitavastatin in Chinese healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Pharmacokinetics of pitavastatin in subjects with Child-Pugh A and B cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effects of pitavastatin on lipid profiles and high-sensitivity CRP in Japanese subjects with hypercholesterolemia: Kansai Investigation of Statin for Hyperlipidemic Intervention in Metabolism and Endocrinology (KISHIMEN) investigatars

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis pr

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

High density lipoprotein cholesterol and apolipoprotein A-I are persistently elevated during long-term treatment with pitavastatin, a new HMG-CoA reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Pitavastatin decreases plasma prebeta1-HDL concentration and might promote its disappearance rate in hypercholesterolemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Short-term effects of pitavastatin on biochemical markers of bone turnover in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Pitavastatin reduces lectin-like oxidized low-density lipoprotein receptor-1 ligands in hypercholesterolemic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Impact of statin therapy on left ventricular function and carotid arterial stiffness in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Pitavastatin improves plasma pentraxin 3 and arterial stiffness in atherosclerotic patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effects of pitavastatin on adiponectin in patients with hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Efficacy of pitavastatin, a new HMG-CoA reductase inhibitor, on lipid and glucose metabolism in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effects of pitavastatin on serum lipids and high sensitivity C-reactive protein in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-dens

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

HMG-CoA reductase inhibitor decreases small dense low-density lipoprotein and remnant-like particle cholesterol in patients with type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Influence of statins on glucose tolerance in patients with type 2 diabetes mellitus: subanalysis of the collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Integrated backscatter and intima-media thickness of the thoracic aorta evaluated by transesophageal echocardiography in hypercholesterolemic patients: effect of pitavastatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Impact of lipid-lowering therapy with pitavastatin, a new HMG-CoA reductase inhibitor, on regression of coronary atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque. Comparison with atorvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Rapid stabilization of vulnerable carotid plaque within 1 month of pitavastatin treatment in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Pitavastatin, an HMG-CoA reductase inhibitor, ameliorates endothelial function in chronic smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Beneficial effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac function in ischemic and nonischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Effects of pitavastatin (LIVALO tablet) on the estimated glomerular filtration rate (eGFR) in hypercholesterolemic patients with chronic kidney disease. Sub-analysis of the LIVALO Effectiveness and Safety (LIVES) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Pitavastatin: efficacy and safety in intensive lipid lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591190-000000000-00000

10.2165/11591190-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference